Cancer Biotherapy and Radiopharmaceuticals

Papers
(The H4-Index of Cancer Biotherapy and Radiopharmaceuticals is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Long Non-Coding RNA AC008972.1 as a Novel Therapeutic Target for Prostate Cancer27
IL-21 and IL-33 May Be Effective Biomarkers to Predict the Efficacy of PD-1 Monoclonal Antibody for Advanced Cholangiocarcinoma26
Synergistic Effects of Ultrasound and Lenvatinib on Proliferation Inhibition and Apoptosis Induction in Hepatocellular Carcinoma Cells25
An LNM-Associated Gene Signature for Prognostic Prediction and Immune Profiling in Head and Neck Squamous Cell Carcinoma22
Mapping the Intersection of Traditional Chinese Medicine and Ultrasound Therapies in Tumor Microenvironment Research (2014–2024): A Knowledge Atlas Study22
Telomere-Related Gene Risk Model for Prognosis and Immune Landscape in Hepatocellular Carcinoma21
Radiopharmaceutical Advancements in Anesthesia and Orthopedic Oncology: A Paradigm Shift in Cancer Biotherapy and Targeted Therapy21
Potential Theranostic Boron Neutron Capture Therapy Agents as Multimodal Radiopharmaceuticals20
Knockdown of Circ_CCNB2 Sensitizes Prostate Cancer to Radiation Through Repressing Autophagy by the miR-30b-5p/KIF18A Axis19
LncRNA MORT Overexpression Inhibits Cancer Cell Migration and Invasion in Hepatocellular Carcinoma by Downregulating NOTCH118
Expression of HER2 and BRCA1 Correlates with Prognosis in Patients with Breast Cancer After Radiotherapy: 16
miR-146a Enhances the Sensitivity of Breast Cancer Cells to Paclitaxel by Downregulating IRAK114
Efficacy and Safety of Drug-Eluting Beads Bronchial Arterial Chemoembolization in Treating Patients with Lung Cancer Who Were Complicated with Hemoptysis13
miR-626 Inhibition Enhanced the Radiosensitivity to Oral Squamous Cell Carcinoma via the Downregulation of Nuclear Factor Kappa-B Signaling13
Long Noncoding RNA Regulator of Reprogramming Regulates Cell Growth, Metastasis, and Cisplatin Resistance in Gastric Cancer via miR-519d-3p/HMGA2 Axis13
0.066052913665771